Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patricia A. Johnson is active.

Publication


Featured researches published by Patricia A. Johnson.


Cancer Research | 2009

Intraoperative Evaluation of Breast Tumor Margins with Optical Coherence Tomography

Freddy T. Nguyen; Adam M. Zysk; Eric J. Chaney; Jan G. Kotynek; Uretz J. Oliphant; Frank J. Bellafiore; Kendrith M. Rowland; Patricia A. Johnson; Stephen A. Boppart

As breast cancer screening rates increase, smaller and more numerous lesions are being identified earlier, leading to more breast-conserving surgical procedures. Achieving a clean surgical margin represents a technical challenge with important clinical implications. Optical coherence tomography (OCT) is introduced as an intraoperative high-resolution imaging technique that assesses surgical breast tumor margins by providing real-time microscopic images up to 2 mm beneath the tissue surface. In a study of 37 patients split between training and study groups, OCT images covering 1 cm(2) regions were acquired from surgical margins of lumpectomy specimens, registered with ink, and correlated with corresponding histologic sections. A 17-patient training set used to establish standard imaging protocols and OCT evaluation criteria showed that areas of higher scattering tissue with a heterogeneous pattern were indicative of tumor cells and tumor tissue in contrast to lower scattering adipocytes found in normal breast tissue. The remaining 20 patients were enrolled into the feasibility study. Of these lumpectomy specimens, 11 were identified with a positive or close surgical margin and 9 were identified with a negative margin under OCT. Based on histologic findings, 9 true positives, 9 true negatives, 2 false positives, and 0 false negatives were found, yielding a sensitivity of 100% and specificity of 82%. These results show the potential of OCT as a real-time method for intraoperative margin assessment in breast-conserving surgeries.


Nicotine & Tobacco Research | 2003

Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting

Gary A. Croghan; Jeff A. Sloan; Ivana T. Croghan; Paul J. Novotny; Richard D. Hurt; Wanda L. DeKrey; James A. Mailliard; Larry P. Ebbert; Debra Swan; Daniel J. Walsh; Martin Wiesenfeld; Ralph Levitt; Philip J. Stella; Patricia A. Johnson; Loren K. Tschetter; Charles L. Loprinzi

This multicenter, randomized, open-label clinical trial was conducted to determine whether the combined use of nicotine patch therapy and a nicotine nasal spray would improve smoking abstinence rates compared to either treatment alone, without behavioral counseling. Data were collected at 15 regional cancer control oncology centers within the North Central Cancer Treatment Group. Of the 1384 smokers randomized to the study, 20% were abstinent from smoking at 6 weeks and 8% were abstinent at 6 months. At 6 weeks, the 7-day point prevalence smoking abstinence rate for the patch alone (21.1%) was superior to the spray (13.6%) but was significantly lower than the rate for combination therapy (27.1%). At 6 months, the 7-day point prevalence abstinence rates were not significantly different among the three groups. Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months.


IEEE Engineering in Medicine and Biology Magazine | 2010

Optical Coherence Tomography: The Intraoperative Assessment of Lymph Nodes in Breast Cancer

Freddy T. Nguyen; Adam M. Zysk; Eric J. Chaney; Steven G. Adie; Jan G. Kotynek; Uretz J. Oliphant; Frank J. Bellafiore; Kendrith M. Rowland; Patricia A. Johnson; Stephen A. Boppart

During breast-conserving surgeries, axillary lymph nodes draining from the primary tumor site are removed for disease staging. Although a high number of lymph nodes are often resected during sentinel and lymph-node dissections, only a relatively small percentage of nodes are found to be metastatic, a fact that must be weighed against potential complications such as lymphedema. Without a real-time in vivo or in situ intraoperative imaging tool to provide a microscopic assessment of the nodes, postoperative paraffin section histopathological analysis currently remains the gold standard in assessing the status of lymph nodes. This paper investigates the use of optical coherence tomography (OCT), a high-resolution real-time microscopic optical-imaging technique, for the intraoperative ex vivo imaging and assessment of axillary lymph nodes. Normal (13), reactive (1), and metastatic (3) lymph nodes from 17 human patients with breast cancer were imaged intraoperatively with OCT. These preliminary clinical studies have identified scattering changes in the cortex, relative to the capsule, which can be used to differentiate normal from reactive and metastatic nodes. These optical scattering changes are correlated with inflammatory and immunological changes observed in the follicles and germinal centers. These results suggest that intraoperative OCT has the potential to assess the real-time node status in situ, without having to physically resect and histologically process specimens to visualize microscopic features.


Cancer | 1993

A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer: An Illinois cancer center study

Timothy M. Kuzel; Martin S. Tallman; Daniel H. Shevrin; Edward L. Braud; Lary J. Kilton; Patricia A. Johnson; James M. Kozlowski; Nicholas J. Vogelzang; Richard Blough; Al B. Benson

Background. 5‐Fluorouracil (5‐FU) has been previously associated with therapeutic benefit in hormone refractory prostate cancer. However, no previous study has administered 5‐FU as a prolonged continuous infusion, which may be the optimal schedule for this cell‐cycle specific agent.


Technology in Cancer Research & Treatment | 2009

Clinical Feasibility of Microscopically-Guided Breast Needle Biopsy Using a Fiber-Optic Probe with Computer-Aided Detection

Adam M. Zysk; Freddy T. Nguyen; Eric J. Chaney; Jan G. Kotynek; Uretz J. Oliphant; Frank J. Bellafiore; Patricia A. Johnson; Kendrith M. Rowland; Stephen A. Boppart

Needle biopsy of small or nonpalpable breast lesions has a high nondiagnostic sampling rate even when needle position is guided by stereotaxis or ultrasound. We assess the feasibility of using a near-infrared fiber optic probe and computer-aided detection for the microscopic guidance of needle breast biopsy procedures. Specimens from nine consented patients undergoing breast-conserving surgery were assessed intraoperatively using a needle device with an integrated fiber-optic probe capable of assessing two physical tissue properties highly correlated to pathology. Immediately following surgical resection, specimens were probed by inserting the optical biopsy needle device into the tissue, simulating the procedure used to position standard biopsy needles. Needle positions were marked and correlated with histology, which verified measurements obtained from 58 needle positions, including 40 in adipose and 18 in tumor tissue. This study yielded tissue classifications based on measurement of optical refractive index and scattering. Confidence-rating schemes yielded combined sensitivity of 89% (16/18) and specificity of 78% (31/40). Refractive index tests alone identified tumor tissue with a sensitivity of 83% (15/18) and specificity of 75% (30/40). Scattering profiles independently identified tumor tissue with a sensitivity of 61% (11/18) and specificity of 60% (24/40). These results show that a biopsy needle with an integrated fiber optic probe can be used to identify breast tumor tissue for sampling. Integration of this probe into current practices offers the potential to reduce nondiagnostic sampling rates by directly evaluating in situ microscopic tissue properties in real-time, before removal.


Proceedings of SPIE | 2007

Portable real-time optical coherence tomography system for intraoperative imaging and staging of breast cancer

Freddy T. Nguyen; Adam M. Zysk; Jan G. Kotynek; Frank J. Bellafiore; Kendrith M. Rowland; Patricia A. Johnson; J. Eric Chaney; Stephen A. Boppart

Breast cancer continues to be one of the most widely diagnosed forms of cancer amongst women and the second leading type of cancer deaths amongst women. The recurrence rate of breast cancer is highly dependent on several factors including the complete removal of the primary tumor and the presence of cancer cells in involved lymph nodes. The metastatic spread and staging of breast cancer is also evaluated through the nodal assessment of the regional lymphatic system. A portable real-time spectral domain optical coherence tomography system is being presented as a clinical diagnostic tool in the intraoperative delineation of tumor margins as well as for real time lymph node assessment. The system employs a super luminescent diode centered at 1310 nm with a bandwidth of 92 nm. Using a spectral domain detection system, the data is acquired at a rate of 5 KHz / axial scan. The sample arm is a galvanometer scanning telecentric probe with an objective lens (f = 60 mm, confocal parameter = 1.5 mm) yielding an axial resolution of 8.3 &mgr;m and a transverse resolution of 35.0 &mgr;m. Images of tumor margins are acquired in the operating room ex vivo on freshly excised human tissue specimen. This data shows the potential of the use of OCT in defining the structural tumor margins in breast cancer. Images taken from ex-vivo samples on the bench system clearly delineate the differences between clusters of tumor cells and nearby adipose cells. In addition, the data shows the potential for OCT as a diagnostic tool in the staging of cancer metastasis through locoregional lymph node assessment.


Investigational New Drugs | 1992

Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas : an Illinois cancer center study

Lary J. Kilton; Al B. Benson; Alice Greenberg; Patricia A. Johnson; Charles L. Shapiro; Richard Blough; Suzanne French; Linda Weidner

SummaryWe have conducted a phase II trial of fludarabine phosphate for advanced measurable adenocarcinoma of the pancreas. The drug was administered every 4 weeks by a daily-times-5 bolus schedule beginning at 20 mg/m2day. No responses were observed in 20 evaluable patients, 18 of whom were previously untreated. Dose-limiting toxicity was leukopenia, and gastroenterologic side effects were frequent. Life-threatening or fatal renal dysfunction occurred in 3 patients. In this schedule fludarabine phosphate is ineffective against adenocarcinoma of the pancreas and appears to have unpredictable severe renal toxicity.


Biophotonics: Photonic Solutions for Better Health Care | 2008

Coherent Optical Imaging and Guided Interventions in Breast Cancer : Translating Technology into Clinical Applications

Stephen A. Boppart; Freddy T. Nguyen; Adam M. Zysk; Eric J. Chaney; Jan G. Kotynek; Uretz J. Oliphant; Frank J. Bellafiore; Kendrith M. Rowland; Patricia A. Johnson

Breast cancer continues to be one of the most widely diagnosed forms of cancer in women and the second leading type of cancer deaths for women. The metastatic spread and staging of breast cancer is typically evaluated through the nodal assessment of the regional lymphatic system, and often this is performed during the surgical resection of the tumor mass. The recurrence rate of breast cancer is highly dependent on several factors including the complete removal of the primary tumor during surgery, and the presence of cancer cells in involved lymph nodes. Hence, developing means to more accurately resect tumor cells, along with the tumor mass, and ensure negative surgical margins, offers the potential to impact outcomes of breast cancer. The use of diffuse optical tomography has been applied for screening optical mammography applications as an alternative to standard x-ray mammography. The use of coherence ranging and coherent optical imaging in breast tissue has also found numerous applications, including intra-operative assessment of tumor margin status during lumpectomy procedures, assessment of lymph node changes for staging metastatic spread, and for guiding needle-biopsy procedures. The development, pre-clinical testing, and translation of techniques such as low-coherence interferometry (LCI) and optical coherence tomography (OCT) into clinical applications in breast cancer is demonstrated in these feasibility studies.


Prostaglandins and Medicine | 1981

Effect of prostaglandin El, E2 or indomethacin on serum parathyroid hormone and calcitonin in the rat

Walter P. Shemerdiak; Subhash C. Kukreja; Patricia A. Johnson

Infusion of 100 or 200 ng/min of Prostaglandin E1 (PGE1) or of 100 ng/min of PGE2 increased serum parathyroid hormone (PTH) in the rat. These infusions, however, had no significant effect on serum calcitonin (CT). Administration of 10 mg/kg of indomethacin for 3 days had no significant effect on basal serum PTH, CT or Calcium (Ca). EDTA infusion increased serum PTH to a similar degree in the vehicle- or indomethacin-treated rats. Therefore, endogenous prostaglandins do not appear to play a role in the secretion of PTH or CT.


Cancer Research | 2009

Optical coherence tomography (OCT) as a diagnostic tool for the real-time intraoperative assessment of breast cancer surgical margins.

Freddy T. Nguyen; Adam M. Zysk; Eric J. Chaney; Jan G. Kotynek; Uretz J. Oliphant; Frank J. Bellafiore; Kendrith M. Rowland; Patricia A. Johnson; Stephen A. Boppart

CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #802 Background: The decrease in the number of breast cancer deaths has largely been attributed to increased awareness, earlier detection, and improved treatment options. However, as the number of breast-conserving surgeries rose over the years, the need for negative margins and little or no residual disease has become critical to help reduce the chances of local recurrence. OCT is a high resolution imaging modality that has been used to image tumor margins in an NMU-carcinogen-induced rat mammary tumor model. Due to the location of breast lesions, the use of needle-based imaging probes may be used to further extend the reach of the OCT imaging beam by incorporating an optical fiber into biopsy needle tips, providing real-time information to guide biopsies or to place localization wires. Material & Methods: A clinical spectral domain OCT system was developed with a super luminescent diode light source centered at 1310 nm with a bandwidth of 92 nm yielding an axial resolution of 8.3 µm. The beam delivery sample arm uses a 60 mm achromatic lens to focus 4.75 mW of light to a 35.0 µm spot size (transverse resolution) with a confocal parameter of 1.47 mm. The patients included in this study had primary breast tumors diagnosed by needle-biopsy and were in need of surgical resection, as determined by their physicians. At Carle Foundation Hospital, the OCT system was placed inside the operating room during breast conserving surgical procedures to image the tissue specimens. The OCT images were evaluated by a single operator allowing for consistent classification based on the level of scattering intensity and heterogeneity, scattering profile, and physical extent of the highly scattering area. Results: An initial training data set of OCT images from 17 patients was used to establish standard imaging protocols and standard evaluation criteria of the surgical margins. Of the 20 additional tissue specimen imaged for the feasibility study, 11 were identified as having a positive or close surgical margin and nine as a negative margin under OCT. In comparing to the H&E histology, there were 9 true positives, 9 true negatives, 2 false positives, and 0 false negatives yielding a sensitivity of 82% and specificity of 100%. Discussion: With an imaging penetration depth of 2-3 mm, equivalent to that used for histological assessment, OCT provides unique real-time cellular-level imaging to identify positive and close margins. In these studies, areas of higher scattering tissue with an irregular or heterogeneous pattern were identified, differentiating them from the abundant adipose tissue found in normal breast tissue. The small nucleus to cytoplasm (N/C) ratio is observed with low-scattering adipocytes compared with the larger N/C ratio found from highly-scattering tumor cells. These intraoperative imaging studies have demonstrated the ability for OCT to identify positive surgical margins. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 802.

Collaboration


Dive into the Patricia A. Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adam M. Zysk

Illinois Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Al B. Benson

Northwestern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James A. Mailliard

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Adina Stanculescu

University of Illinois at Chicago

View shared research outputs
Researchain Logo
Decentralizing Knowledge